fashion -WSS

fashion

author：Wikipedia 2025-10-01 11:19:57 - browse：33

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

focus

leisure time

WSS

Readout Newsletter: XBI biotech index, Akero Therapeutics

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Patient advocates debate FDA's accelerated approval process

Cassava reveals details — and problems — with Alzheimer's study

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Supreme Court mifepristone arguments center on docs' right to sue

entertainment

fashion

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

Biden's order seeks to regulate AI risk without stifling innovation

Medical records are filled with copy

Paying for Covid pills will soon shift to insurers

What does generative AI mean for health care? We asked experts

Maker of FluMist seeks to allow at

Cancer drug shortages should be causing more outrage

Why Sanofi got shellacked over its spinoff

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: XBI biotech index, Akero Therapeutics

focus

Food as medicine: Medically tailored meals may get standardized

Washington mulls new rules to avert another Change Healthcare

Abortion pill Supreme Court ruling could impact entire drug industry

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Why the world’s most expensive drug might be worth the price

Readout Newsletter: XBI biotech index, Akero Therapeutics

focus

leisure time

focus

Wikipedia